HORNBACH Baumarkt AG
- WKN: 608440
- ISIN: DE0006084403
- Land: Deutschland
Nachricht vom 26.07.2021 | 13:05
HORNBACH Baumarkt AG: Board of Management resolves share buyback for employee share program 2021
HORNBACH Baumarkt AG / Key word(s): Share Buyback
Board of Management resolves share buyback for employee share program 2021
Bornheim, July 26, 2021. The Board of Management of HORNBACH Baumarkt AG, based in Bornheim/Pfalz, ISIN DE0006084403, today resolved to acquire up to 55,000 treasury stock shares pursuant to § 71 (1) No. 2 of the German Stock Corporation Act (AktG). The shares are to be acquired in preparation for the
The buyback of shares on the basis of this management board resolution will be executed in accordance with the safe harbor regulations set out in Article 5 of Regulation (EU) No. 596/2014 of the European Parliament and Council dated April 14, 2014 and with the delegated Regulation (EU) 2016/1052 of the Commission dated March 8, 2016.
The buyback of shares will begin on August 9, 2021 and will run for a limited period expiring at the end of the 2021/22 financial year (balance sheet date: February 28, 2022). The purchase price to be paid by the company per share (excluding acquisition costs) may not exceed or fall short of the stock market price by more than 10%. The stock market price referred to corresponds to the average of the closing prices in Xetra trading at the Frankfurt Stock Exchange on the five trading days immediately preceding the respective acquisition. Moreover, the shares will not be acquired at a price in excess of that determined pursuant to Article 3 (2) of the delegated Regulation (EU) 2016/1052 of the Commission dated March 8, 2016. Buyback orders will only be submitted during continuous trading and not within auction phases. Orders in place at the beginning of an auction phase will not be amended during such phase. The maximum total purchase price for which shares are to be acquired by HORNBACH Baumarkt AG amounts to Euro 2,500,000.00.
The buyback of shares will be executed in such a way as to protect the interests of the market and will be managed by a bank that determines the timing of the treasury stock purchases at its own discretion and without influence from the company.
In respect of the volume of shares to be acquired per day, it will not be permitted to acquire more than 25% of the respective average daily trading volume in Xetra trading at the Frankfurt Stock Exchange. The average daily trading volume of the respective trading segment is derived by reference to average daily trading volumes on the 20 trading days preceding the respective acquisition.
Information on transactions related to the repurchase program shall be appropriately disclosed in accordance with Art. 2 par. 2 and 3 of the Delegate Regulation (EU) 2016/1052 at the latest by the end of the seventh trading day following the day on which such transactions are executed. In addition, in accordance with Art. 2 para. 3 of the Delegate Regulation, the company will publish the announced transactions on its website www.hornbach-holding.de under Investor Relations/ Shares/Share Buyback and ensure that the information remains publicly accessible for at least five years from the date of announcement.
Group Communications and Investor Relations Director
HORNBACH Holding AG & Co. KGaA
Tel. +49 (0) 6348 602444
|Company:||HORNBACH Baumarkt AG|
|76878 Bornheim bei Landau/Pfalz|
|Phone:||+49 (0)6348 / 60 00|
|Fax:||+49 (0)6348 / 60 40 00|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1221496|
|End of Announcement||DGAP News Service|
HORNBACH Baumarkt AG: Hornbach Baumarkt AG upg ...
HORNBACH Baumarkt AG: Preliminary announcement ...
HORNBACH Baumarkt AG: Preliminary announcement ...
HORNBACH Baumarkt AG: Board of Management reso ...
HORNBACH Baumarkt AG: Hochwasser-Geschädigte e ...
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
03. Dezember 17:00 DAX: Der nächste Nackenschlag
03. Dezember 17:54 Börsenpunk: DAX - Angst ist zurück an den Märkten - jetzt trotzdem ...
03. Dezember 18:09 Alibaba, Tencent und Co: Kleiner Crash vorm Wochenende
03. Dezember 18:19 Musterdepot-Titel BHP: Es geht voran
03. Dezember 19:02 Dow Jones: Es hört nicht auf ...
News im Fokus
Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an
03. Dezember 2021, 07:03
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen
02. Dezember 2021